CTX

Welcome to the Brand page for “CTX”, which is offered here for Research and development services in the field of pharmaceuticals for the treatment of attention deficit/hyperactivity disorder (adhd); conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention- deficit/hyperactivity disorder (adhd);.

Its status is currently believed to be active. Its class is unavailable. “CTX” is believed to be currently owned by “Cingulate Therapeutics LLC”.